Alleviation of adipose tissue inflammation and obesity suppression by a probiotic strain that induces GLP-1 secretion
These include: These symptoms happen because retatrutide affects gut hormone pathways involved in appetite, digestion and weight regulation
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)
2, 2024 (HealthDay News) -- Weight loss tops many folks list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds
BMI 27.0 to 29.9 (overweight with potential eligibility)
Meanwhile, scientists have been uncovering new roles of GLP-1-based drugs beyond diabetes and obesity, with early data suggesting that they may be used to treat cardiovascular diseases, addictive disorders, and neurodegenerative disorders